Ignite Creation Date:
2025-12-25 @ 3:28 AM
Ignite Modification Date:
2026-01-15 @ 1:52 PM
Study NCT ID:
NCT02657005
Status:
TERMINATED
Last Update Posted:
2025-02-12
First Post:
2016-01-12
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
TK216 in Patients With Relapsed or Refractory Ewing Sarcoma
Sponsor:
Oncternal Therapeutics, Inc
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-08
Start Date Type:
ACTUAL
Primary Completion Date:
2022-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-06
Completion Date Type:
ACTUAL
First Submit Date:
2016-01-12
First Submit QC Date:
None
Study First Post Date:
2016-01-15
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2024-08-27
Results First Submit QC Date:
None
Results First Post Date:
2024-11-07
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-01-29
Last Update Post Date:
2025-02-12
Last Update Post Date Type:
ACTUAL